30 closest matches · ranked by relevance
Arrhythmias, Cardiac
Primary: Device Malfunction — 24; 52 Participants
Magnetic Resonance Imaging
Primary: Percentage of Participants Free From MR (Magnetic Resonance) Scan-related Complications — 100 percentage of participants
Bradycardia
Primary: Freedom From MRI Scan-related Complications — 123 Participants — p=<0.01
Adverse Effect of MRI on an Implanted Pacemaker Lead · Adverse Effect of MRI on an Implanted Pacemaker
Primary: Freedom From Right Atrial (RA) Lead-related Complications in the Acute Period — 97.2 percentage of subjects
Bradycardia · Slow Heart Beat
Primary: Magnetic Resonance Imaging (MRI)-Related Complications — 0 participants — p=<0.001
Cardiac Arrhythmia
Primary: The Proportion of MRI Scans From Pacemakers or CRT-Ps Providing Sufficient Image Quality to Allow for a Diagnostic Interpretation. — 129 MRI Scans
Bradycardia
Primary: Number of MRI Related Patient Adverse Events and/or Adverse Device Effects During MRI Visit — 0 number of MRI related patient adverse ev
Tachycardia
Primary: Number of Participants With Freedom From Magnetic Resonance Imaging (MRI) Scan Related Complications — 14; 14; 15; 12 Participants
MRI Scans · Magnetic Resonance Imaging · Pacemaker
Primary: Number of Participants With Burning or Pulling Sensations in Chest/Device Pocket During MRI — 2 Participants
Bradycardia
Primary: Freedom From RA and RV Lead-related Complications — 97.19; 99.14 percentage of participants
Cardiomyopathy
Primary: Cardiac Ejection Fraction — 64; 66; 65; 62 Percent
Magnetic Resonance Imaging (MRI); Cardiac Pacing
Primary: MRI and Pacing System Related Serious Adverse Device Effect (SADE) Free Rate — 99.5 percentage of participants
Magnetic Resonance Imaging (MRI) · Cardiac Pacing
Primary: MRI-related Complication Free Rate — 156 participants — p=<0.0001
Bradycardia · Tachycardia · Heart Failure
Primary: The Occurrence of an MRI-related Event for CIED — 59; 0 Participants — p=0.002
Safety of the ProMRI Pacemaker System Under Specific MRI Conditions
Primary: MRI and Pacing System Related Serious Adverse Device Effect (SADE) Free Rate — 100 percentage of participants
Bradycardia · Sinus Node Dysfunction
Primary: Proportion of Participants Without MR Scan-related Complications — 100 Percentage of participants
Implantable Defibrillator
Primary: MRI-related Events — 147 Participants free of MRI-related events — p=<0.0001
ICD · Tachycardia
Primary: Number of Participants With Freedom From MRI-scan Related Complications* Related to St. Jude Medical™ MR Conditional ICD System — 177 Participants
Clinical Indication for a Head MRI
Primary: Number of Head Images Successfully Collected — 10 Images
Magnetic Resonance Imaging · Cardiac Pacemaker, Artificial
Primary: Magnetic Resonance Imaging (MRI)-Related Complications — 0 participants — p=<0.0001
Coronary Disease
Primary: Major Adverse Cardiovascular Events — 0 Participants
Cardiac Pacemaker, Artificial
Primary: Implant Success — 75.36 % of subjects with successful implant
Cervical Cancer
Primary: Number of Participants With Improved Image Quality in the Shifted Position — 0; 15 Participants
Poor Peripheral Perfusion
Primary: MRI Based Radial Artery Measurement — 1.35 millimeters
Acute Coronary Syndrome · Chest Pain
Primary: Cost of Index Hospitalization — 2062; 2680 US Dollars
Heart Failure
Primary: Change in Left Ventricle End-Systolic Volume Index (LVESVI) — -11.6; -4.1 mL/m^2 — p=0.0001
Myocardial Perfusion Imaging · Magnetic Resonance Imaging
Primary: Percentage Agreement Between Gadobutrol Perfusion Magnetic Resonance Imaging (MRI) (Blinded Reading) and SPECT (Central Reading) Regarding the Diagnosis for Detection of…
Coronary Heart Disease
Primary: Number of Participants With Unnecessary Invasive Coronary Angiography — 36; 34; 69 Participants
Fetal Arrhythmia · Abnormality in Fetal Heart Rate or Rhythm · Long QT Syndrome
Primary: Percentage of Subjects Experiencing Symptoms — 0; 0 Participants
Peripheral Arterial Disease (PAD)
Primary: Segment-level Sensitivity and Specificity of VE-MRI at 3 Ferumoxytol Dosing Levels and Differences in Sensitivity and Specificity by Dose Group — 71.8; 76.8; 81.8; 71.2…